---
figid: PMC9569594__ijms-23-11457-g009
pmcid: PMC9569594
image_filename: ijms-23-11457-g009.jpg
figure_link: /pmc/articles/PMC9569594/figure/ijms-23-11457-f009/
number: Figure 9
figure_title: ''
caption: 'The relative concentrations of the metabolites. Notes: The relative concentrations
  of the metabolites involved in the glycolytic pathway and triacylglycerol pathway
  (part) in MDA-MB-231 cells (red) and MCF-7 cells (blue) after treatment with compound
  1 in duration of 48 h. Data are expressed as the mean value Â± SD of three independent
  experiments. Columns, mean of cells; bars, SD; * p < 0.05; *** p < 0.001; SD, standard
  deviation; purple text indicates metabolites concentrations changed after treatment
  in both cell lines; ER, endoplasmatic reticulum; ADP, adenosine diphosphate; ATP,
  adenosine triphosphate; GLC-6-P, glucose-6-phosphate; glycerol-3-P, glycerol-3-phosphate;
  DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; Ac-CoA, acetyl-coenzyme
  A.'
article_title: Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem
  Cell Fraction Inducing Shift of Lipid to Glucose Metabolism.
citation: Matij Pervan, et al. Int J Mol Sci. 2022 Oct;23(19):11457.
year: '2022'

doi: 10.3390/ijms231911457
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- breast cancer cells
- cancer stem cells
- newly synthesized thieno [2,3-b]pyridine compound
- glycosphingolipids
- metabolomics

---
